Kwyktel Beta 25 Tablet ER
Marketer
Kwykewl Pharma Pvt. Ltd.
Salt Composition
Telmisartan (40mg) + Metoprolol Succinate (25mg)
Overview Kwyktel Beta 25 Tablet ER
Beta-25 Extended-Release tablets manage hypertension, reducing the risk of strokes and heart attacks. Early use improves heart attack survival rates. Take this medication daily with food for consistent blood levels, following your doctor's instructions precisely. Do not discontinue use independently, even feeling well, as hypertension is often asymptomatic. Maintaining a healthy lifestyle, including exercise, weight management, and balanced nutrition, complements treatment. Consult your physician regarding dosage and potential interactions. Possible side effects include headache, weakness, dizziness, hypotension (sometimes with fainting), shortness of breath, nausea, vomiting, abdominal pain, fatigue, and elevated potassium levels. Avoid potassium-rich foods and supplements. Dizziness may occur; avoid driving and rise slowly. Regular monitoring of blood pressure, blood sugar, kidney function, urea, and electrolytes may be required. Inform your doctor about any pre-existing liver or kidney conditions, or if you are pregnant or breastfeeding. Always disclose all medications, particularly those for hypertension or cardiac issues.
Uses of Kwyktel Beta 25 Tablet ER
Managing Elevated Blood Pressure
Major Benefits of Kwyktel Beta 25 Tablet ER:
Consume Kwyktel Beta 25 Tablet ER precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take this medication with food.
Common Side effects of Kwyktel Beta 25 Tablet ER:
- Headache
- Weakness
- Dizziness
- Cold extremities
- Slow heart rate
- Increased potassium level in blood
- Decreased blood pressure
- Orthostatic hypotension (sudden lowering of blood pressure on standing)
- Breathlessness
- Vomiting
- Abdominal pain
How to use Kwyktel Beta 25 Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for Kwyktel Beta 25 Tablet ER. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with food.
How Kwyktel Beta 25 Tablet ER works:
Kwyktel Beta 25 Extended-Release tablets contain a dual-action formulation of telmisartan and metoprolol succinate, both agents contributing to reduced blood pressure.
SAFETY ADVICE
AlcoholUNSAFE
Combining Kwyktel Beta 25 Tablet ER and alcohol is inadvisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
Extended-release Kwyktel Beta 25 Tablets pose a confirmed risk to a developing fetus and should not be taken during pregnancy. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential advantages outweigh the known hazards. Physician consultation is essential.
Breast feedingSAFE IF PRESCRIBED
Extended-release Kwyktel Beta 25 tablets are likely safe for use while breastfeeding. Available human data indicates minimal risk to the infant.
DrivingUNSAFE
Extended-release Kwyktel Beta 25 tablets can cause drowsiness, blurred vision, and dizziness, potentially impairing alertness. Driving should be avoided if these effects are experienced.
KidneySAFE IF PRESCRIBED
Kwyktel Beta 25 Extended-Release tablets pose no safety concerns for patients with renal impairment; no dosage modification is necessary.
LiverCAUTION
Exercise caution when administering Kwyktel Beta 25 Extended-Release tablets to individuals with hepatic impairment; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Kwyktel Beta 25 Tablet ER :
Should you forget a Kwyktel Beta 25 Tablet ER dose, take it immediately if remembered. If, however, your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Kwyktel Beta 25 Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Heart |



